Showing results (201-210 of 362) with videos related to
Sort By:
Pageof 37
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 2, 2022
Cost-Effectiveness of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer: An Economic Evaluation Based on Network Meta-AnalysisLin Wang, Hwanhee Hong, G Caleb Alexander, et al.Pharmacoepidemiology and Drug Safety|August 4, 2010
Racial and ethnic disparities in cardiovascular medication use among older adults in the United StatesDima M Qato, Stacy Tessler Lindau, Rena M Conti, et al.JAMA Surgery|August 3, 2017
Prescription Opioid Analgesics Commonly Unused After Surgery: A Systematic ReviewMark C Bicket, Jane J Long, Peter J Pronovost, et al.JAMA Network Open|October 2, 2020
Use and Content of Primary Care Office-Based vs Telemedicine Care Visits During the COVID-19 Pandemic in the USG Caleb Alexander, Matthew Tajanlangit, James Heyward, et al.Breast Cancer Research and Treatment|November 15, 2012
Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004-2010Stacie B Dusetzina, G Caleb Alexander, Rachel A Freedman, et al.Obesity (Silver Spring, Md.)|November 21, 2025
Weight Changes From Glucagon-Like Peptide-1 Receptor Agonist Use and Discontinuation: A Retrospective Cohort StudyG Caleb Alexander, Yizhen Xu, Xuya Xiao, et al.American Journal of Nephrology|December 14, 2018
Trends in Opioid Prescribing Among Hemodialysis Patients, 2007-2014Matthew Daubresse, G Caleb Alexander, Deidra C Crews, et al.Journal of Surgical Orthopaedic Advances|November 30, 2018
Opioid Prescriptions After Total Joint ArthroplastyUdai S Sibia, Abigail E Mandelblatt, G Caleb Alexander, et al.Drug and Alcohol Dependence|June 27, 2021
Primary care physicians' preparedness to treat opioid use disorder in the United States: A cross-sectional surveyKathryn Foti, James Heyward, Matthew Tajanlangit, et al.Annals of Internal Medicine|January 9, 2008
The effect of the Medicare Part D prescription benefit on drug utilization and expendituresWesley Yin, Anirban Basu, James X Zhang, et al.Pageof 37